$APLS ranked +1 on 4-Sep-19

$APLS ranked +1 on 4-Sep-19

Apelis Pharmaceuticals (APLS, +1) – Timothy Sullivan (CFO since 2017; Board observer 2014-2017) purchased 11,699 shares on August 29 at $29.71, spending $347,000 in his first purchase in the stock. Sullivan has been involved with this company since 2014, and CFO since 2017. It is unusual to see him make his first purchase now, especially after the stock has moved up to a recent multi-year high. We did not find ownership requirements listed in the proxy prompting the purchase. Sullivan owns 165,000 options in addition to the shares he just purchased. We are ranking the stock +1 based on this large “out of the blue” purchase from the CFO.

If you are interested in our Stocks of the Week
those services may also be useful for you

Desktop
Service

Timely data delivery customised to every user, backed by analysis tools on our internal website

Signals
Data

We rank the stocks where transactions are most likely to indicate future share price performance

Shares
Buybacks

Studying buyback activity can give a clue to the fortunes of a company and help predict future share price movement

If you are a member of the media and would like to speak with a Smart Insider expert, please contact us press@smartinsider.com or call +44 203 405 3356

Scroll to Top